Document Detail


Oral rivaroxaban for the treatment of symptomatic pulmonary embolism: are we ready?
MedLine Citation:
PMID:  24626121     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
Clinical questionCan an oral regimen of rivaroxaban be used for the treatment of symptomatic pulmonary embolism?Article chosenBüller H, Prins M, Lensing A, et al. Oral rivaroxaban for the treatment of symptomatic pulmonary embolism. N Engl J Med 2012;366:1287-97.ObjectiveTo determine the effectiveness and safety of oral rivaroxaban in the treatment of symptomatic pulmonary embolism when compared to current standard therapy.
Authors:
Martin Kuuskne; Jerrald Dankoff
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  CJEM     Volume:  16     ISSN:  1481-8035     ISO Abbreviation:  CJEM     Publication Date:  2014 Mar 
Date Detail:
Created Date:  2014-03-14     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100893237     Medline TA:  CJEM     Country:  United States    
Other Details:
Languages:  eng     Pagination:  155-7     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Epinephrine compared to placebo in cardiac arrest resuscitation.
Next Document:  Lateral medullary syndrome: a diagnostic approach illustrated through case presentation and literatu...